Phase 2 Partners’s CME Group CME Stock Holding History

Phase 2 Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,756	Closed	-$5.68M	–	28
2024 Q3	$5.68M	Buy	+25,756	New	+$5.33M	3.36%	13
2023 Q3	–	Sell	-1,765	Closed	-$327K	–	22
2023 Q2	$327K	Sell	1,765 -102,395	-98%	-$18.9M	0.15%	23
2023 Q1	$19.9M	Buy	+104,160	New	+$18.8M	8.6%	1
2022 Q2	–	Sell	-4,020	Closed	-$956K	–	26
2022 Q1	$956K	Sell	4,020 -15,524	-79%	-$3.65M	0.62%	21
2021 Q4	$4.46M	Buy	+19,544	New	+$4.3M	2.76%	17

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Phase 2 Partners's CME Position: Q4 2024 in Review

Phase 2 Partners sold out of CME Group (CME) in Q4 2024, closing a stake of 25,756 shares — an estimated $5.68M sold.

Phase 2 Partners first reported a position in CME in Q4 2021 and held it in 5 quarters. The position peaked at $19.9M in Q1 2023. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

Phase 2 Partners reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
Phase 2 Partners sold 25,756 CME Group shares in Q4 2024, an estimated $5.68M.
Phase 2 Partners first reported a position in CME Group in Q4 2021 and held it in 5 quarters.
Phase 2 Partners's CME Group position peaked at $19.9M in Q1 2023.
1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Phase 2 Partners's 13F filing for Q4 2024, filed 14 Feb 2025.